Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages ...
Silexion Therapeutics Corp. (SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
P/E ratio (year end quote, basic EPS) 253.37 259.61 - - P/E ratio (year end quote, diluted EPS) 253.37 259.61 - - Silexion Therapeutics Dividend Calendar Silexion Therapeutics Calendar Indices ...
After hours: 7:59:51 p.m. EST Loading Chart for SLXN ...
Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.
CURRENC Group Inc. operates fintech platform for e-wallets, financial institutions, and merchants worldwide. The company’s services include merchant payment, global remittance, global bill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results